Weiwei Shen

Dr. Weiwei Shen

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
WSWeiwei Shen
Weiwei Shen
TYTongyao You
Tongyao You
WXWenqing Xu
Wenqing Xu
YXYanan Xie
Yanan Xie
YWYingzhe Wang
Yingzhe Wang
MCMei Cui
Mei Cui
Intranasal administration is a promising strategy to enhance the delivery of the sEVsomes-based drug delivery system to the central nervous system (CNS). This study aimed to explore central distributive characteristics of mesenchymal stem cell-derived small extracellular vesicles (MSC-sEVs) and underlying pathways. Here, we observed that intranasal MSC-sEVs were rapidly distributed to various brain regions, especially in the subcortex distant from the olfactory bulb, and were absorbed by multiple cells residing in these regions. We captured earlier transportation of intranasal MSC-sEVs into the perivascular space and found an increase in cerebrospinal fluid influx after intranasal administration, particularly in subcortical structures of anterior brain regions where intranasal sEVs were distributed more significantly. These results suggest that the perivascular pathway may underlie the rapid and widespread central delivery kinetics of intranasal MSC-sEVs and support the potential of the intranasal route to deliver MSC-sEVs to the brain for CNS therapy.

30 November 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
YYYiwen Yuan
Yiwen Yuan
JSJian Sun
Jian Sun
TYTongyao You
Tongyao You
WSWeiwei Shen
Weiwei Shen
WXWenqing Xu
Wenqing Xu
MCMei Cui
Mei Cui
Neurological diseases remain some of the major causes of death and disability in the world. Few types of drugs and insufficient delivery across the blood–brain barrier limit the treatment of neurological disorders. The past two decades have seen the rapid development of extracellular vesicle-based therapeutics in many fields. As the physiological and pathophysiological roles of extracellular vesicles are recognized in neurological diseases, they have become promising therapeutics and targets for therapeutic interventions. Moreover, advanced nanomedicine technologies have explored the potential of extracellular vesicles as drug delivery systems in neurological diseases. In this review, we discussed the preclinical strategies for extracellular vesicle-based therapeutics in neurological disorders and the struggles involved in their clinical application.

16 October 2019 in Science China Life Sciences
Verified
Journal Article
Closed access
PDF file
WSWeiwei Shen
Weiwei Shen
LMLingyu Ma
Lingyu Ma
Xi ZhangXi Zhang
Xi Zhang
XLXixia Li
Xixia Li
YZYuanyuan Zhao
Yuanyuan Zhao
JLJinxing Lin
Jinxing Lin

13 April 2026 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
YYYiwen Yuan
Yiwen Yuan
SLSuzhen Liang
Suzhen Liang
AGAo Guan
Ao Guan
JSJian Sun
Jian Sun
WSWeiwei Shen
Weiwei Shen
MCMei Cui
Mei Cui
White matter hyperintensities (WMH), characterized by myelin loss and axonal injury, are largely driven by hypertension, their most significant modifiable